Trials / Unknown
UnknownNCT02509390
Hyperfibrinogenemia After Major Trauma
Hyperfibrinogenemia Within the First Days After Major Trauma : Kinetic, Functionality, Impact of Fibrinogen Replacement Therapy and Trauma, Thrombosis Risk
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Assessment of the evolution of fibrinogen plasma level within the first ten days after major trauma in order to determine prevalence of hyperfibrinogenemia (Fg \> 4 g/L) and its time to onset.
Detailed description
In this study, investigators daily investigate fibrinogen plasma levels and fibrinogen antigen in severe trauma patients (Injury severity score \> 15) within the first ten days. Investigators then modelize hyperfibrinogenemia profiles according to severity of injuries and physiopathologic mechanisms. Finally, investigators determine predisposing risk factors to develop hyperfibrinogenemia and assess the impact of fibrinogen replacement therapy in initial phase of management of major trauma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood samples | Investigators analyze hematological parameters with blood sampled daily in severe trauma patients |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2015-07-28
- Last updated
- 2015-07-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02509390. Inclusion in this directory is not an endorsement.